Erythropoietin (Procrit; Epogen) revisited.
D001782:Blood Donors; D001804:Blood Transfusion, Autologous; D004305:Dose-Response Relationship, Drug; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000009:adverse effects / Q000627:therapeutic use*; D005252:Fees, Pharmaceutical; D015658:HIV Infections / Q000188:drug therapy; D006397:Hematinics / Q000627:therapeutic use*; D006977:Hypertension, Renal / Q000139:chemically induced; D009369:Neoplasms / Q000188:drug therapy; D011292:Premedication; D011300:Preoperative Care / Q000379:methods; D011994:Recombinant Proteins; D051437:Renal Insufficiency / Q000188:drug therapy
D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa